Form 4: Avanos Medical SVP, General Counsel Mojirade James Reports Tax Withholding Transaction

Mojirade James, SVP, General Counsel of Avanos Medical, Inc., reports the surrender of shares to cover tax obligations upon vesting of restricted share units.

Summary

• On March 5, 2024, Mojirade James, SVP, General Counsel of Avanos Medical, Inc., reported a transaction involving common stock.
• 2,190 shares were surrendered to the issuer to satisfy tax withholding obligations.
• This was due to the vesting of time-based restricted share units (TRSUs) awarded on March 4, 2022.
• One-third of these TRSUs vested on March 4, 2023, another third on March 4, 2024, and the final third will vest on March 4, 2025.
• The price per share for the transaction was $18.76.
• Following the transaction, James directly owns 42,253 shares of Avanos Medical, Inc.

Sentiment

Score: 5

Explanation: This is a neutral transaction related to tax obligations, with no inherent positive or negative implications for the company's performance.

Industry Context

This is a routine Form 4 filing, which is common for corporate insiders who have transactions in their company's stock. It provides transparency into the trading activities of key personnel.

Key Dates